Clinical Trials Directory

Trials / Completed

CompletedNCT03773900

Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to demonstrate the beneficial effects on gut microbiota composition and activity of the diary intake of insoluble fiber (extract from Aspergillus Niger) for three weeks. The first studies about the fiber have shown a favorable gut microbiota modulation and an improvement of metabolic parameters like LDL cholesterol. In addition to fecal measurements, several biomarkers of colic fermentation will be assessed: expired gases, PolyUnsaturated Fatty Acid, Short Chain Fatty Acid (SCFA) after a rich-fiber breakfast (= 15 grams) and a nutritional challenge test at lunch. The gastrointestinal tolerance of fiber intake and the intestinal transit modification will be also followed during all the study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKiotransine (chitin-glucan from aspergillus niger)The volunteers will take three times a day one bag of powder containing 1.5g of chitin-glucan fiber during three weeks. The powder will be diluted in water.
DIETARY_SUPPLEMENTPlaceboThe volunteers will take three times a day one bag of powder containing placebo during three weeks. The powder will be diluted in water.

Timeline

Start date
2018-11-07
Primary completion
2019-06-06
Completion
2019-06-06
First posted
2018-12-12
Last updated
2025-09-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03773900. Inclusion in this directory is not an endorsement.